Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's disease in the UK and Germany

Walter E, Odin P.
J Med Econ. 2015 Feb; 18(2):155-65.

Link: http://informahealthcare.com


Socio-economic aspects of the testing for antibodies in MS-Patients under Interferon Therapy in Austria: A cost of Illness Study

Walter E, Deisenhammer F.
Multiple Sclerosis and Related Disorders. 2014, Volume 3, Issue 6, Pages 670-677.

Link: http://www.msard-journal.com


Kosteneffektivität der primärprofilatischen Gabe von Pegfilgrastim vs. Filgrastim bei Brustkrebspatienten in Österreich

Walter E
Recht der Medizin Beilage Gesundheit und Ökonomie, Dezember 2013


Cost Efectividad del Tratamiento de la Anemia inducida por quimioteerapia con agentes estimuladores dela Eritropoyesis

Rodríguez CA, Alegre A, Cassinello J, Guiérrez L, Crespo C, Villacampa A, Walter E
PharmaEconomics Spanish Resarch Articles, August 2013

Link: http://paperity.org


Pharmaökonomische Aspekte von Biosimilars : Kosteneffektivitätsvorteil?

Walter E
Pharmazie in unserer Zeit; Volume 41, Issue 6, pages 485-491, November 2012

Link: http://onlinelibary.wiley.com


Cost analysis: treatment of chemotherapy-induced anemia with erythropoiesis-stimulating agents in five European countries

Duran A, Spaepen E, Lamotte M, Walter E, Umuhire D, Lucioni C, Pinheiro B, Brosa M, Kutikova L, Pujol B, Van Belle S, Annemans L
J Med Econ. 2012; 15(3): 409-18

Link: http://informahealthcare.com


Access to pharmaceutical products in six European countries – analysis of different pharmaceutical distribution systems

E. Walter, A. Dragosits, M. Said
in: Farmaeconomia. Health economics and therapeutic pathways 2012; 13(1): 33-41
download (PDF 970 kb)

Link zum Journal: www.edizioniseed.it


Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria

B. Resch, C. Sommer, M.J.C. Nuijten, S. Seidinger, E. Walter, V. Schöllbauer, W.D. Mueller
in: The Pediatric Infectious Disease Journal 2012; 31
Link: http://journals.lww.com/pidj/pages/articleviewer.aspx?year=2012&issue=01000&article=00011&type=abstract


Cost analysis of neonatal and pediatric parenteral nutrition in Europe – a multi-country study

E. Walter, F.X. Liu, P. Maton, T. Storme, M. Perrinet, O. von Delft, J. Puntis, D. Hartigan, A. Dragosits, S. Sondhi
in: European Journal of Clinical Nutrition 2012
Link: http://www.nature.com/ejcn/journal/vaop/ncurrent/full/ejcn2011225a.html


How to save money: congenital CMV infection and the economy

E. Walter, C. Brennig, V. Schöllbauer
In: Congenital Cytomegalovirus Infection,
Halwachs-Baumann, Gabriele (Ed.), Springer
Wien New York 2011


Impact of stereotactic 11-g vacuum- assisted breast biopsy on cost of diagnosis in Austria

R. Gruber, E. Walter, Th. Helbich
in: European Journal of Radiology, October 2009


Cost comparison between ultrasound-guided 14-g large core breast biopsy and open surgical biopsy: An analysis for Austria

R. Gruber, E. Walter, Th. Helbich
In: European Journal of Radiology, March 2009


Oncological costs of medicine amongst a health economic context

Walter E., Batista A.

(only available in GERMAN)
In: Wiener Medizinische Wochenschrift 2008


„Economic aspects in Rheumatology”

Walter E.

(only available in GERMAN)
In: top medizin, Fachzeitschrift für Innere
und Allgemeinmediziner, Heft 01/2008


„Cost-effectiveness of 45 mg leuprorelin acetate administered every 6 months for the treatment of the progressed prostate carcinoma in Austria”

Brennig C., Walter E.

(only available in GERMAN)
in: Recht der Medizin, Beilage Ö&G, Heft 01/2008


„Cost-effectiveness of Rosuvastin vs. Simavastatin: 1st Line Treatment in Austria”

Zehetmayr S., Walter E.

(only available in GERMAN)
in: Krause & Pachernegg,
Journal für Kardiologie, Nummer 7-8/2007


“Cost-effective prevention of chemotherapy-induced nausea and regurgitate (CINV) in the supportive care of cancer patients”

Zehetmayr S., Walter E.

(only available in GERMAN)
in: Recht der Medizin, Beilage Ö&G,
Heft 03 / 2007


„Cost-effectiveness of Solifenacin in the treatment of the overactive bladder in Austria”

Walter E., Brennig C.

(only available in GERMAN)
in: Recht der Medizin, Beilage Ö&G, Heft 03 / 2007


„Palonosetron – cost-effective prevention of the chemotherapy-induced nausea and regurgitate (CINV)“

Walter E., Zehetmayr S., Achzet G.
Posterpräsentation bei der ÖGHO - Frühjahrestagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; 12.04-14.04.2007

(only available in GERMAN)
download (PDF 619 KB)


“Theoretical implications for health economic evaluation with outlook to Austria”

Walter E., Zehetmayr S.
in: Wiener Medizinische Wochenschrift 156. Jahrgang, Heft 23/24 Dezember 2006

(only available in GERMAN)
download (PDF 2MB)


„Guidelines on health economic evaluation – Consesus paper“

Walter E., Zehetmayr S.
in: Wiener Medizinische Wochenschrift
156. Jahrgang, Heft 23/24 Dezember 2006

(only available in GERMAN)
download (PDF 1MB)


„Highly effective and cost-effective“

In: CliniCum 12/2006

(only available in GERMAN)
download (PDF 96kb)


„Austrian Guidelines for health economic evaluation“

Walter E.

(only available in GERMAN)
in: PharmacoEconomics German
Research Articles 2006; 4 (2): 55-63


„Darbepoetin alfa in the treatment of chemotherapy-induced anemia”

Walter E.

(only available in GERMAN)
in: Krankenhauspharmazie,
27. Jahrgang, Heft 1, Januar 2006
Seiten 24-31


„Dimension of the Austrian health care expenditures for 2003"

Walter E., in:
Wirtschaftspolitische Blätter 4/2005

(only available in GERMAN)
download (PDF 1,00 mb)


"Important driver of innovation and economic factors"

In: Pharmig info 2/2005

(only available in GERMAN)
download (PDF 890 kb)


„Healthy value growth“

In: Pharmig News - eine Beilage der Pharmig in Wirtschaftsblatt und Medianet
25. November 2005

(only available in GERMAN)
download (PDF 1,35 mb)


"Pharmaceutical industry contributes one billion to the Austrian value-added”

In: Standard 24.11.2005

(only available in GERMAN)
download (PDF 960 kb)


„Reliable data for effective reforms“

Walter E., in: Apotheker Krone 2/05

(only available in GERMAN)
download (PDF 1,35 mb)


6 wishes for a rationale health reform

Walter E., in: Welldone 12/2004

(only available in GERMAN)
download (PDF 635 kb)


"Scientific Models & Political realities in the health care sytem"

Vienna, 30.11.2004
Walter E.

(only available in GERMAN)
www.hauptverband.at/mediaDB/88109.pdf


Useful life - good harvest

Walter E., in: Innenwelt Nr.2/2004

(only available in GERMAN)
download (PDF 100 kb)


Cost-effectiveness of Escitalopram versus Citalopram in the Treatment of severe Depression in Austria

Hemels M., Kasper S., Walter E., Enron T., in: Value in Health, Vol. 7, No. 3/2004
download (PDF 296 kb)


Cost factor depression

Walter E., in: CliniCum psy, Ausgabe Nr. 3/2004, S. 8-9

(only available in GERMAN)
download (PDF 1,23 mb)


In the service of health economics

Walter E., in: Pharmig Info, Ausgabe Nr. 2/2004, S. 20-21

(only available in GERMAN)
download (PDF 792 kb)


Chronic funding crisis in the health care system

Walter E., in: Glocalist , Ausgabe Nr. 36/2004, S. 12-13

(only available in GERMAN)
download (PDF 915 kb)


The Supreme Court judgment: Opportunities for health funding from one source?

Clement W., in: Doktor in Wien, 11/2003

(only available in GERMAN)
download (PDF 1,41 mb)


Mirtazapine - a cost-effective treatment of depression: an Austrian analysis

Walter E. in: Journal für Neurologie, Neurochirurgie und Psychiatrie Nr. 3/2003

(only available in GERMAN)
(Link zum Artikel: http://journals.imc.akh-wien.ac.at/kup/pdf/3558.pdf)


Profit margins on pharmaceutical products: The game with the percentages

Walter E., OTS-Meldung 06.08.2003

(only available in GERMAN)
download (PDF 264 kb)